1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (494)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5599)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5599)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II multicenter, open-label study of oral ENMD-2076 for the treatment of patients with advanced fibrolamellar carcinoma
    Journal Article

    Abou-Alfa, G. K.; Mayer, R.; Venook, A. P.; O'Neill, A. F.; Beg, M. S.; LaQuaglia, M.; Kingham, P. T.; Kobos, R.; Basturk, O.; Brennan, C.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Phase Ib study of enzalutamide with or without sorafenib in patients with advanced hepatocellular carcinoma
    Journal Article

    Harding, J. J.; Kelley, R. K.; Tan, B.; Capanu, M.; Do, G. K.; Shia, J.; Chou, J. F.; Ferrer, C. S.; Boussayoud, C.; Muenkel, K.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor
    Journal Article

    Zhang, J. Q.; Bosbach, B.; Loo, J. K.; Vitiello, G. A.; Zeng, S.; Seifert, A. M.; Medina, B. D.; Param, N. J.; Maltbaek, J. H.; Rossi, F.; more...
    Oncogene (2020)

    Fulltext@MSK | Save
  • Sarcomatoid renal cell carcinoma: Biology, natural history and management
    Review

    Blum, K. A.; Gupta, S.; Tickoo, S. K.; Chan, T. A.; Russo, P.; Motzer, R. J.; Karam, J. A.; Hakimi, A. A.
    Nature Reviews Urology (2020)

    Fulltext@MSK | Save
  • Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: Feasibility and preliminary efficacy of the Beat AML Master Trial
    Research Letter

    Burd, A.; Levine, R. L.; Ruppert, A. S.; Mims, A. S.; Borate, U.; Stein, E. M.; Patel, P.; Baer, M. R.; Stock, W.; Deininger, M.; more...
    Nature Medicine (2020)

    Fulltext@MSK | Save
  • Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
    Journal Article

    Ghione, P.; Qi, S.; Imber, B. S.; Seshan, V.; Moskowitz, A.; Galasso, N.; Lunning, M.; Straus, D.; Sauter, C.; Dahi, P.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Insertion of an Alu-like element in MLH1 intron 7 as a novel cause of Lynch syndrome
    Journal Article

    Li, Y.; Salo-Mullen, E.; Varghese, A.; Trottier, M.; Stadler, Z. K.; Zhang, L.
    Molecular Genetics and Genomic Medicine (2020)

    Fulltext@MSK | Save
  • An attention-supervised full-resolution residual network for the segmentation of breast ultrasound images
    Journal Article

    Qu, X.; Shi, Y.; Hou, Y.; Jiang, J.
    Medical Physics (2020)

    Fulltext@MSK | Save
  • Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
    Journal Article

    Samstein, R. M.; Krishna, C.; Ma, X.; Pei, X.; Lee, K. W.; Makarov, V.; Kuo, F.; Chung, J.; Srivastava, R. M.; Purohit, T. A.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
    Journal Article

    Fraser, G. A. M.; Chanan-Khan, A.; Demirkan, F.; Santucci Silva, R.; Grosicki, S.; Janssens, A.; Mayer, J.; Bartlett, N. L.; Dilhuydy, M. S.; Loscertales, J.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save